Ms. Sonya Satveit reports

OPEN SOURCE HEALTH AND GENEYOUIN ANNOUNCE ADVANCES IN FERTILITY CARE USING PERSONALIZED MEDICINE

Open Source Health Inc. is leading the digital transformation of integrative medicine with its cloud-based health care platform. Open Source puts control into the hands of women to educate, advocate and collaborate on their own health care and is converging integrative medicine and personalized medicine in guiding treatment of the No. 1 cause of infertility: polycystic ovarian syndrome (PCOS).

"This is very personal for me, and I am committed to helping women get access to the latest advancements in reproductive medicine," stated Sonya Satveit, founder and chief executive officer of Open Source Health. "It is personalized medicine, combined with an integrative approach, that will drive our care programs, guide physicians and ultimately provide women with the best chance at a positive outcome."

According to the World Health Organization, 116 million women worldwide suffer with polycystic ovarian syndrome, making it the leading endocrine disorder among women and the No. 1 cause of female infertility. The first line of treatment involves lifestyle modifications, after which debate remains over the use of the two most common drugs, Metformin and Clomifene, in dealing with the infertility that often accompanies PCOS.

"Personalized medicine allows physicians to work with their patients to uncover the best forms of treatment and mitigate risks with precautionary measures," stated Dr. Ruslan Dorfman, chief executive officer and founder of Genyouin Inc., a company based in Toronto, Canada.

"At GeneYouIn, we are excited to be working with OSH to reach women with PCOS and provide them with state-of-the-art genomic sequencing technology specific to their needs."

A simple and non-invasive genetic test can identify genetic variations in women with PCOS and help guide treatment in two ways: first, by identifying genetic variations, which can determine how well a woman will respond to Clomifene, a common pharmacologic treatment for women with infertility; secondly, women with PCOS are already at high risk for miscarriage, and by identifying specific genetic variations that put these women at higher risk for miscarriage, physicians can plan precautionary measures. A woman's full genetic report, stored within the Open Source platform, can assist physicians and patients in devising a personalized treatment plan, including preventative measures that are tailored based on their genetic makeup.

About GeneYouIn

GeneYouIn provides genetic testing and consulting services to executive, fertility and other specialty clinics, as well as to individuals. GeneYouIn's products aim to inform clients, as well as their health care providers, about genetic variations that may affect drug response and inherited disease risks, to help optimize health management. To provide unique insights on an individual's health, GeneYouIn developed innovative software solutions for pharmacogenetic genome annotation available for clinical diagnostic laboratories. A genetic test from GeneYouIn provides invaluable, actionable information about an individual's genetic makeup, enabling one to take targeted, pro-active steps toward a healthy and active life. For more information, visit the GeneYouIn website.

We seek Safe Harbor.